logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Hammertoe Market, By Type (Flexible and Rigid), By End User (Hospital, Clinics, Orthopaedic Center, Physiotherapy Centers) opportunities and forecast 2020-2027

  • DLR2164
  • 23 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Hammertoe is feet-related issue, in which feet bend permanently. Problem occurs because of an imbalance in the muscles and ligaments that hold toe straight. Hammertoe bends toe downward in place of keeping it straight. One reasons causing hammertoe comprises wearing small or narrow size shoes that curve the toe. Further reasons that can lead to the disease include muscle or vein damage, rheumatoid arthritis, stroke, osteoarthritis, Charcot–Marie–Tooth disease, and various other feet problems.

The pain and discomfort caused due to the disease can be controlled by shifting the footwear. Generally, the disease occurs due to incorrect selection of the shoes that affects the toe muscles, but in few cases, the problem may be existing by birth itself. The growing prevalence of the arthritis and the growing R&D expenditure in healthcare industry boost the market growth. Though, factors such as difficulties and pain related with surgeries, risk of contagions during the surgical treatments and the hospital stay, and lack of awareness are anticipated to hinder market growth.

Segment Overview

Based on the type, the global market is segmented into flexible and rigid. In case of flexible, the joints in toe can be straightened and moved. Flexible hammertoes cause pain and impatience and lead to the expansion of the corns and calluses. It is vital to treat the hammertoes, even if toe is flexible. As per Andrew Park, the Senior Manager at Orthopedics, a global medical device, pharmaceutical market firm in 2017, more than 648,000 hammertoe surgeries were performed in the US.

Arthritis is common joint-related disease, which may happen due to age and osteoporosis. Arthritis is one of reasons causing the hammertoe at almost any age. According to Centers for Disease Control and Prevention (CDC), in February 2018 the prevalence of the arthritis is growing with age. It has been projected that 54.4 million of population has been identified with arthritis, of which 23.4 % of the women and 18.1% of the men had arthritis. It was projected that 78.4 million people over 18 years are expected to be identified with arthritis by the year 2040 in the U.S. So, the growing prevalence of the arthritis among population will boost market growth.

Regional Overview

North America is pioneer in foot and ankle surgery and held largest market in global hammertoe market in 2019. Due to availability of the top-class healthcare infrastructure, the prompt adoption of new products and treatments and advanced medical facilities. North American market is rising continuously. Many top companies are operating from the region, which is leading to the innovation and new product growths. Other factors, such as availability of skilled healthcare professionals, and the availability of products coupled with the high purchasing power, also boost growth of the market. According to 2012 survey National Foot Health Assessment lead by the NPD Group for Institute for Preventive Foot Health, 3% of the U.S. adults aged between 21 and older have experienced hammertoe and claw toe.
Due to the swelling healthcare spending and rapidly emerging healthcare sector, Asia-Pacific is anticipated to be fastest-growing region in global hammertoe market over the forecast period.

Key Players
  1. Stryker,
  2. Smith & Nephew,
  3. Zimmer Biomet Holdings,
  4. Extremity Medical LLC,
  5. Nextremity Solutions, Inc.,
  6. Arrowhead Medical Device Technologies LLC,
  7. Wright Medical Group N.V.,
  8. Nextremity Solutions, Inc.,
  9. BioPro.

Market Segmentation
By Type
  • Flexible
  • Rigid
By End User
  • Hospitals
  • Clinics
  • Physiotherapy Centre
  • Orthopaedic Centre
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 12

    2 Market Introduction 14

    • 2.1 Scope of Study 15
    • 2.2 Research Objective 15
    • 2.3 List of Assumptions 15

    3 Research Methodology 17

    • 3.1 Research Process 18
    • 3.2 Primary Research 19
    • 3.3 Secondary Research 20
    • 3.4 Market Size Estimation 21

    4 Market Dynamics 22

    • 4.1 Introduction 23
    • 4.2 Drivers 23
      • 4.2.1 Increasing prevalence of arthritis among the population 23
      • 4.2.2 Growing R&D expenditure in the healthcare industry 23
    • 4.3 Restraints 23
      • 4.3.1 Risk of infections during surgical treatments and hospital stay 23
    • 4.4 Opportunity 23
      • 4.4.1 Technological advancements in hammertoe products 23

    5 Market Factor Analysis 24

    • 5.1 Porter’s Five Forces Analysis 25
      • 5.1.1 Introduction 25
      • 5.1.2 Bargaining Power of Suppliers 25
      • 5.1.3 Bargaining Power of Buyers 26
      • 5.1.4 Threat of New Entrants 26
      • 5.1.5 Threat of Substitutes 26
      • 5.1.6 Intensity of Rivalry 26
    • 5.2 Value Chain Analysis 27
      • 5.2.1 Introduction 27
      • 5.2.2 Primary Activities 27
        • 5.2.2.1 Inbound logistics 27
        • 5.2.2.2 Production and operation 27
        • 5.2.2.3 Outbound logistics 27
      • 5.2.3 Secondary Activities 27

    6 Global Hammertoe Market, by Type 28

    • 6.1 Introduction 29
    • 6.2 Rigid 30
    • 6.3 Flexible 30

    7 Global Hammertoe Market, by Treatment & Diagnosis 31

    • 7.1 Introduction 32
    • 7.2 Treatment 33
    • 7.3 Diagnosis 33

    8 Global Hammertoe Market, by End User 34

    • 8.1 Introduction 35
    • 8.2 Hospitals & Clinics 36
    • 8.3 Physiotherapy & Orthopedic Centers 36

    9 Global Hammertoe Market, by Region 37

    • 9.1 Introduction 38
    • 9.2 Americas 40
      • 9.2.1 North America 42
        • 9.2.1.1 U.S 44
        • 9.2.1.2 Canada 45
      • 9.2.2 South America 47
    • 9.3 Europe 49
      • 9.3.1 Western Europe 51
        • 9.3.1.1 Germany 53
        • 9.3.1.2 U.K 54
        • 9.3.1.3 France 56
        • 9.3.1.4 Italy 57
        • 9.3.1.5 Spain 59
        • 9.3.1.6 Rest of Western Europe 60
      • 9.3.2 Eastern Europe 62
    • 9.4 Asia Pacific 64
      • 9.4.1 Japan 66
      • 9.4.2 China 67
      • 9.4.3 India 69
      • 9.4.4 Australia 70
      • 9.4.5 Republic of Korea 72
      • 9.4.6 Rest of Asia Pacific 73
    • 9.5 Middle East & Africa 75
      • 9.5.1 Middle East 77
      • 9.5.2 Africa 78

    10 Competitive Landscape 80

    • 10.1 Introduction 81

    11 Company Profiles 82

    • 11.1 Stryker 83
      • 11.1.1 Company Overview 83
      • 11.1.2 Financial Overview 83
      • 11.1.3 Products/Services Offered 83
      • 11.1.4 SWOT Analysis 84
      • 11.1.5 Key Developments 84
      • 11.1.6 Key strategy 84
    • 11.2 Smith & Nephew 85
      • 11.2.1 Company Overview 85
      • 11.2.2 Financial Overview 85
      • 11.2.3 Products/Services Offered 86
      • 11.2.4 Key Developments 86
      • 11.2.5 SWOT Analysis 86
      • 11.2.6 Key Strategy 86
    • 11.3 Zimmer Biomet Holdings 87
      • 11.3.1 Company Overview 87
      • 11.3.2 Financial Overview 87
      • 11.3.3 Products/Services Offered 87
      • 11.3.4 Key Developments 88
      • 11.3.5 SWOT Analysis 88
      • 11.3.6 Key Strategy 88
    • 11.4 Extremity Medical LLC 89
      • 11.4.1 Company Overview 89
      • 11.4.2 Financial Overview 89
      • 11.4.3 Products/Services Offered 89
      • 11.4.4 Key Developments 89
      • 11.4.5 SWOT Analysis 90
      • 11.4.6 Key Strategy 90
    • 11.5 Nextremity Solutions, Inc. 91
      • 11.5.1 Company Overview 91
      • 11.5.2 Financial Overview 91
      • 11.5.3 Products/Services Offered 91
      • 11.5.4 Key Developments 91
      • 11.5.5 SWOT Analysis 91
      • 11.5.6 Key Strategy 91
    • 11.6 Arrowhead Medical Device Technologies LLC 92
      • 11.6.1 Company Overview 92
      • 11.6.2 Financial Overview 92
      • 11.6.3 Products/Services Offered 92
      • 11.6.4 Key Developments 92
      • 11.6.5 SWOT Analysis 92
      • 11.6.6 Key Strategy 92
    • 11.7 Wright Medical Group N.V. 93
      • 11.7.1 Company Overview 93
      • 11.7.2 Financial Overview 93
      • 11.7.3 Products/Services Offered 94
      • 11.7.4 Key Developments 94
      • 11.7.5 SWOT Analysis 94
      • 11.7.6 Key Strategy 94
    • 11.8 Nextremity Solutions, Inc. 95
      • 11.8.1 Company Overview 95
      • 11.8.2 Financial Overview 95
      • 11.8.3 Products/Services Offered 95
      • 11.8.4 Key Developments 95
      • 11.8.5 SWOT Analysis 95
      • 11.8.6 Key Strategy 96
    • 11.9 BioPro 97
      • 11.9.1 Company Overview 97
      • 11.9.2 Financial Overview 97
      • 11.9.3 Products/Services Offered 97
      • 11.9.4 Key Developments 97
      • 11.9.5 SWOT Analysis 97
      • 11.9.6 Key Strategy 98

    12 Appendix 99

    • 12.1 Discussion Blue Print 100

    Report You Might be Interested